Whole body vibration exposures in forklift operators: comparison of a mechanical and air suspension seat.
Using a repeated measures design, this study compared differences in whole body vibration (WBV) exposures when 12 forklift operators drove the same forklift with a mechanical suspension and an air suspension seat. A portable PDA-based WBV data acquisition system collected and analysed time-weighted and raw WBV data per ISO 2631-1 and 2631-5 WBV measurement standards. Tri-axial measurements of weighted vibration (A(w)), crest factor, vibration dose values, time-weighted average-peak, raw (+) peak, raw (-) peak and static compression dose (S(ed)) were compared between seats. There were significant differences in z-axis WBV exposures with the air suspension seat, yielding lower WBV exposures. In addition, there were differences between seats in how they attenuated WBV exposures based on the driver's weight. In the mechanical suspension seat, WBV exposures were weight-dependent, with lighter drivers having higher WBV exposures, whereas with the air suspension seat, the same trends were not as prevalent. STATEMENT OF RELEVANCE: This study contributes to the understanding of how different seat suspensions can influence WBV transmission and how some components of vibration transmission are dependent on the weight of the driver. Additional systematic studies are needed to quantify how various factors can influence WBV exposures.
School of Public Health, Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.
Ryan P
RP
Blood
James D
JD
Ploger
Peter W
PW
Johnson
D000328:Adult; D000704:Analysis of Variance; D001835:Body Weight; D003625:Data Collection; D004867:Equipment Design; D006804:Ergonomics; D006801:Humans; D017116:Low Back Pain / Q000517:prevention & control*; D008875:Middle Aged; D009784:Occupational Diseases / Q000517:prevention & control*; D016273:Occupational Exposure / Q000517:prevention & control*; D018709:Statistics, Nonparametric; D014732:Vibration / Q000009:adverse effects*